Invesco Ltd. - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 221 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$30,593,235
+159.9%
1,160,153
+69.5%
0.01%
+166.7%
Q2 2023$11,772,866
+1232.0%
684,469
+1184.0%
0.00%
Q1 2023$883,846
+172.1%
53,308
+25.1%
0.00%
Q4 2022$324,818
-89.8%
42,627
-86.6%
0.00%
-100.0%
Q3 2022$3,170,000
+708.7%
318,882
+638.0%
0.00%
Q2 2022$392,000
-12.7%
43,209
-2.2%
0.00%
Q1 2022$449,000
-43.7%
44,190
-7.6%
0.00%
Q4 2021$798,000
-67.8%
47,839
-9.5%
0.00%
-100.0%
Q3 2021$2,478,000
-12.9%
52,866
+13.3%
0.00%0.0%
Q2 2021$2,845,000
+88.8%
46,659
+90.6%
0.00%
Q1 2021$1,507,000
-42.0%
24,474
-33.0%
0.00%
-100.0%
Q4 2020$2,598,000
+1070.3%
36,532
+519.1%
0.00%
Q3 2020$222,000
-21.8%
5,901
-39.7%
0.00%
Q1 2020$284,000
+18.3%
9,792
+42.9%
0.00%
Q4 2019$240,0006,8510.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders